CYTOSORBENTS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CYTOSORBENTS CORPORATION (CTSO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 100.67 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 49.96K shares, a 1.34% decline year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 50.71K shares, a 8.17% increase year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 1.67M shares, a 347.52% increase year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 13.47K shares, a 88.04% decline year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 1.78M shares, a 27.93% increase from fiscal 2024.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.39M shares, a 42.82% increase from fiscal 2023.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 974.55K shares, a 23.27% decline from fiscal 2022.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.27M shares, a 820.16% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 49.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 100.67K shares 10-Q · filed 2026-08-06 | 1.77M shares derived: sum of 3 quarters · filed 2026-08-06 | 1.78M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 50.71K shares 10-Q · filed 2026-05-13 | 1.72M shares derived: sum of 2 quarters · filed 2026-05-13 | 1.73M shares derived: sum of 3 quarters · filed 2026-05-13 | 1.78M shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 1.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 1.68M shares derived: sum of 2 quarters · filed 2026-03-30 | 1.73M shares derived: sum of 3 quarters · filed 2026-03-30 | 1.78M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 13.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 64.11K shares derived: sum of 2 quarters · filed 2025-11-13 | 110.98K shares 10-Q · filed 2025-11-13 | 484.09K shares derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | 50.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 97.51K shares 10-Q · filed 2025-08-07 | 470.62K shares derived: sum of 3 quarters · filed 2026-03-30 | 583.25K shares derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | 46.88K shares 10-Q · filed 2025-05-14 | 419.98K shares derived: sum of 2 quarters · filed 2026-03-30 | 532.61K shares derived: sum of 3 quarters · filed 2026-03-30 | 1.06M shares derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | 373.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 485.73K shares derived: sum of 2 quarters · filed 2026-03-30 | 1.01M shares derived: sum of 3 quarters · filed 2026-03-30 | 1.39M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 112.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 636.54K shares derived: sum of 2 quarters · filed 2024-11-07 | 1.02M shares 10-Q · filed 2024-11-07 | 1.24M shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | 523.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 906.17K shares 10-Q · filed 2024-08-13 | 1.13M shares derived: sum of 3 quarters · filed 2025-03-31 | 1.48M shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | 382.26K shares 10-Q · filed 2024-05-09 | 608.43K shares derived: sum of 2 quarters · filed 2025-03-31 | 958.29K shares derived: sum of 3 quarters · filed 2025-03-31 | 1.03M shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | 226.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 576.04K shares derived: sum of 2 quarters · filed 2025-03-31 | 648.02K shares derived: sum of 3 quarters · filed 2025-03-31 | 974.55K shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 349.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 421.84K shares derived: sum of 2 quarters · filed 2023-11-09 | 748.38K shares 10-Q · filed 2023-11-09 | 797.06K shares derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-06-30 | 71.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 398.52K shares 10-Q · filed 2023-08-01 | 447.20K shares derived: sum of 3 quarters · filed 2024-03-15 | 484.63K shares derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-03-31 | 326.54K shares 10-Q · filed 2023-05-02 | 375.22K shares derived: sum of 2 quarters · filed 2024-03-15 | 412.65K shares derived: sum of 3 quarters · filed 2024-03-15 | 491.57K shares derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-12-31 | 48.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 86.11K shares derived: sum of 2 quarters · filed 2024-03-15 | 165.03K shares derived: sum of 3 quarters · filed 2024-03-15 | 1.27M shares 10-K · filed 2024-03-15 |
| 2022-09-30 | 37.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 116.35K shares derived: sum of 2 quarters · filed 2022-11-03 | 1.22M shares 10-Q · filed 2022-11-03 | 1.25M shares derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-06-30 | 78.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 1.18M shares 10-Q · filed 2022-08-02 | 1.21M shares derived: sum of 3 quarters · filed 2024-03-15 | 1.25M shares derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-03-31 | 1.11M shares 10-Q · filed 2022-05-03 | 1.14M shares derived: sum of 2 quarters · filed 2024-03-15 | 1.17M shares derived: sum of 3 quarters · filed 2024-03-15 | 1.20M shares derived: sum of 4 quarters · filed 2024-03-15 |
| 2021-12-31 | 30.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 61.40K shares derived: sum of 2 quarters · filed 2024-03-15 | 90.20K shares derived: sum of 3 quarters · filed 2024-03-15 | 138.04K shares 10-K · filed 2024-03-15 |
| 2021-09-30 | 31.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 60.01K shares derived: sum of 2 quarters · filed 2021-11-04 | 107.85K shares 10-Q · filed 2021-11-04 | 110.85K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | 28.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 76.64K shares 10-Q · filed 2021-08-03 | 79.64K shares derived: sum of 3 quarters · filed 2023-03-09 | 97.11K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | 47.83K shares 10-Q · filed 2021-05-04 | 50.83K shares derived: sum of 2 quarters · filed 2023-03-09 | 68.30K shares derived: sum of 3 quarters · filed 2023-03-09 | 79.51K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | 3.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 20.47K shares derived: sum of 2 quarters · filed 2023-03-09 | 31.68K shares derived: sum of 3 quarters · filed 2023-03-09 | 34.64K shares 10-K · filed 2023-03-09 |
| 2020-09-30 | 17.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 28.68K shares derived: sum of 2 quarters · filed 2020-11-04 | 31.64K shares 10-Q · filed 2020-11-04 | 683.26K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | 11.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 14.17K shares 10-Q · filed 2020-08-04 | 665.79K shares derived: sum of 3 quarters · filed 2022-03-10 | 685.82K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | 2.97K shares 10-Q · filed 2020-05-05 | 654.59K shares derived: sum of 2 quarters · filed 2022-03-10 | 674.61K shares derived: sum of 3 quarters · filed 2022-03-10 | 715.82K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | 651.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 671.64K shares derived: sum of 2 quarters · filed 2022-03-10 | 712.85K shares derived: sum of 3 quarters · filed 2022-03-10 | 747.67K shares 10-K · filed 2022-03-10 |
| 2019-09-30 | 20.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 61.23K shares derived: sum of 2 quarters · filed 2019-11-05 | 96.05K shares 10-Q · filed 2019-11-05 | 585.40K shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-06-30 | 41.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 76.03K shares 10-Q · filed 2019-08-06 | 565.37K shares derived: sum of 3 quarters · filed 2021-03-09 | 576.29K shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-03-31 | 34.82K shares 10-Q · filed 2019-05-07 | 524.16K shares derived: sum of 2 quarters · filed 2021-03-09 | 535.08K shares derived: sum of 3 quarters · filed 2021-03-09 | 562.46K shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2018-12-31 | 489.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 500.26K shares derived: sum of 2 quarters · filed 2021-03-09 | 527.65K shares derived: sum of 3 quarters · filed 2021-03-09 | 544.67K shares 10-K · filed 2021-03-09 |
| 2018-09-30 | 10.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 38.30K shares derived: sum of 2 quarters · filed 2018-11-06 | 55.32K shares 10-Q · filed 2018-11-06 | 203.40K shares derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | 27.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 44.41K shares 10-Q · filed 2018-08-02 | 192.49K shares derived: sum of 3 quarters · filed 2020-03-05 | 192.49K shares derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | 17.02K shares 10-Q · filed 2018-05-08 | 165.10K shares derived: sum of 2 quarters · filed 2020-03-05 | 165.10K shares derived: sum of 3 quarters · filed 2020-03-05 | 170.94K shares derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | 148.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | 148.08K shares derived: sum of 2 quarters · filed 2020-03-05 | 153.92K shares derived: sum of 3 quarters · filed 2020-03-05 | 165.72K shares 10-K · filed 2020-03-05 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 5.84K shares derived: sum of 2 quarters · filed 2017-11-09 | 17.64K shares 10-Q · filed 2017-11-09 | 213.26K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | 5.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 17.64K shares 10-Q · filed 2017-08-07 | 213.26K shares derived: sum of 3 quarters · filed 2019-03-07 | 213.26K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | 11.80K shares 10-Q · filed 2017-05-08 | 207.42K shares derived: sum of 2 quarters · filed 2019-03-07 | 207.42K shares derived: sum of 3 quarters · filed 2019-03-07 | 703.02K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | 195.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 195.62K shares derived: sum of 2 quarters · filed 2019-03-07 | 691.22K shares derived: sum of 3 quarters · filed 2019-03-07 | 695.77K shares 10-K · filed 2019-03-07 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 495.60K shares derived: sum of 2 quarters · filed 2016-11-07 | 500.15K shares 10-Q · filed 2016-11-07 | 501.85K shares derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | 495.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 500.15K shares 10-Q · filed 2016-08-09 | 501.85K shares derived: sum of 3 quarters · filed 2018-03-08 | 515.66K shares derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | 4.55K shares 10-Q · filed 2016-05-09 | 6.25K shares derived: sum of 2 quarters · filed 2018-03-08 | 20.06K shares derived: sum of 3 quarters · filed 2018-03-08 | 64.22K shares derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | 1.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 15.51K shares derived: sum of 2 quarters · filed 2018-03-08 | 59.67K shares derived: sum of 3 quarters · filed 2018-03-08 | 166.29K shares 10-K · filed 2018-03-08 |
| 2015-09-30 | 13.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | 57.97K shares derived: sum of 2 quarters · filed 2015-11-13 | 164.59K shares 10-Q · filed 2015-11-13 | |
| 2015-06-30 | 44.16K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 150.78K shares 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | 106.62K shares 10-Q · filed 2015-05-11 | |||
| 2014-12-31 | 227.81K shares 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |